OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,478 | +41.8% | 13,399 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $116,686 | +116.1% | 12,922 | +1.4% | 0.00% | – |
| Q1 2022 | $54,000 | -56.8% | 12,739 | -4.8% | 0.00% | -100.0% |
| Q4 2021 | $125,000 | -67.1% | 13,388 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $380,000 | +100.0% | 13,790 | +102.9% | 0.00% | +100.0% |
| Q2 2021 | $190,000 | -19.1% | 6,796 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $235,000 | – | 7,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
| BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
| Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
| Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
| VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
| Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
| Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
| HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
| RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |